{"id":"49a0443e-3414-40a3-9f90-cadc315966ae","modelId":"4e82b737-eeed-40fa-96b8-c426df7e5c52","versionId":null,"locationId":"f42cb087-b4c0-49ea-97b6-d47fcfa6f304","operatorId":"0cd83b28-d0e9-4f17-be61-c9d20d2b618f","ownerId":null,"slug":"motif-bci-germany-europe","status":"operational","firstSeen":"2024-06-01T00:00:00.000Z","statusChangeReason":null,"contractType":null,"pilotOutcome":null,"endedAt":null,"unitsOnSite":null,"tasksPerformed":["identity_verification","access_control","security_screening"],"shiftStructure":null,"hoursPerDay":24,"siteType":"commercial","operatorConfirmed":null,"humanSupervisionOnsite":null,"locationPrecisionTier":"city_centroid","deploymentScale":"medium_11_100","siteEnvironment":"indoor","operatorType":"customer_deployed","sourceQualityTier":8,"manufacturerSerial":null,"reviewStatus":"unreviewed","sources":[],"notes":"Commercial product — available for purchase in this market.","keyFacts":[],"reviewNote":"Bulk deepened — form-factor-based metadata assignment","exposureHours":null,"deploymentMilesEstimate":null,"exposureBasis":null,"customerSegment":"retail","scaleTier":"commercial_10_99","contractValueUsd":null,"contractValueBasis":null,"customerCompanyId":null,"customerExternalName":null,"createdAt":"2026-08-20T04:09:15.144Z","updatedAt":"2026-10-21T22:44:23.140Z","model":{"id":"4e82b737-eeed-40fa-96b8-c426df7e5c52","companyId":"0cd83b28-d0e9-4f17-be61-c9d20d2b618f","modelName":"Motif BCI","slug":"motif-bci","description":"Wirelessly powered implantable BCI delivering targeted brain stimulation for treatment-resistant depression.","formFactor":"biometric","industryVertical":"healthcare","environment":"indoor","maturityStage":"pilot","lifecycleState":"active","supersededByModelId":null,"specs":{},"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[{"url":"https://news.rice.edu/news/2026/brain-computer-interface-based-rice-research-wins-fda-approval-first-clinical-trial","title":"Brain-computer interface based on Rice research wins FDA approval for first clinical trial","sourceName":"Rice University News"}],"aliases":[],"collisionRisk":"low","reviewNote":null,"manufacturerTermForTeleop":null,"keyFacts":[{"label":"DOT implant (reported, Apr 2026)","value":"A wirelessly powered, blueberry-sized implant in the skull above the dura that stimulates depression-linked circuits without touching the brain."},{"label":"FDA feasibility study (reported, Apr 2026)","value":"FDA cleared an early feasibility study for adults with treatment-resistant depression; the exemption came four years after founding, per Rice University."},{"label":"Study sites and population (reported, Apr 2026)","value":"Sites include Baylor College of Medicine and Massachusetts General Brigham; Motif puts the patient group at nearly 3 million Americans."}],"createdAt":"2026-08-08T22:32:35.975Z","updatedAt":"2026-10-12T21:48:28.076Z","unitsInFieldClaimed":null,"unitsInFieldVerified":null,"unitsManufacturedClaimed":null,"unitsManufacturedVerified":null,"unitsAsOf":null,"unitsSource":null,"salesModel":null,"priceUndisclosedSince":null,"autonomyClass":null,"autonomyStatement":null,"autonomyStatementSource":null,"demoForensics":null,"exportControlClass":null,"minCommitment":null,"warrantyTerms":null,"serviceModel":null,"productionRateClaimed":null,"productionRateEvidenced":null,"teleopRatioDisclosed":null,"interventionRateDisclosed":null,"company":{"id":"0cd83b28-d0e9-4f17-be61-c9d20d2b618f","name":"Motif Neurotech","slug":"motif-neurotech","description":"Motif Neurotech is a Houston-based brain-computer interface company developing an implantable therapeutic BCI for treatment-resistant depression. Its [Motif BCI](/models/motif-bci) XCS System is a wirelessly-powered implant delivering electrical stimulation to brain circuits linked to depression. FDA approved its first clinical trial (RESONATE) in April 2026, making Motif the fastest implantable BCI company from founding to IDE approval.","status":"private","founded":2022,"hq":"Houston, Texas, USA","hqLat":29.7589382,"hqLng":-95.3676974,"hqGeocodedAt":"2026-08-23T21:16:59.827Z","hqAddress":null,"hqPrecision":null,"website":"motifneuro.tech","fundingTotal":"18750000","type":"hardware","roles":["robot_maker","robot_operator"],"reviewStatus":"reviewed","heatIndex":75,"lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://news.rice.edu/news/2026/brain-computer-interface-based-rice-research-wins-fda-approval-first-clinical-trial","title":"Brain-computer interface based on Rice research wins FDA approval for first clinical trial","sourceName":"Rice University News"}],"keyFacts":[{"label":"FDA","value":"IDE approved April 2026"},{"label":"Indication","value":"Treatment-resistant depression"},{"label":"Program","value":"ARPA-H behavioral health"},{"label":"Origin","value":"Rice University research"}],"aliases":[],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":null,"stockExchange":null,"secCik":null,"revenueUsd":null,"revenueBasis":null,"revenueAsOf":null,"employeeCount":null,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-08-08T22:32:35.528Z","updatedAt":"2026-08-21T22:31:16.597Z"}},"version":null,"location":{"id":"f42cb087-b4c0-49ea-97b6-d47fcfa6f304","name":"Germany, Europe","slug":"germany-europe","kind":"country","parentLocationId":null,"region":"Western Europe","lat":null,"lng":null,"reviewStatus":"reviewed","aliases":[],"collisionRisk":"high","reviewNote":null,"createdAt":"2026-08-20T04:07:01.358Z","updatedAt":"2026-08-21T03:20:12.226Z"},"operator":{"id":"0cd83b28-d0e9-4f17-be61-c9d20d2b618f","name":"Motif Neurotech","slug":"motif-neurotech","description":"Motif Neurotech is a Houston-based brain-computer interface company developing an implantable therapeutic BCI for treatment-resistant depression. Its [Motif BCI](/models/motif-bci) XCS System is a wirelessly-powered implant delivering electrical stimulation to brain circuits linked to depression. FDA approved its first clinical trial (RESONATE) in April 2026, making Motif the fastest implantable BCI company from founding to IDE approval.","status":"private","founded":2022,"hq":"Houston, Texas, USA","hqLat":29.7589382,"hqLng":-95.3676974,"hqGeocodedAt":"2026-08-23T21:16:59.827Z","hqAddress":null,"hqPrecision":null,"website":"motifneuro.tech","fundingTotal":"18750000","type":"hardware","roles":["robot_maker","robot_operator"],"reviewStatus":"reviewed","heatIndex":75,"lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://news.rice.edu/news/2026/brain-computer-interface-based-rice-research-wins-fda-approval-first-clinical-trial","title":"Brain-computer interface based on Rice research wins FDA approval for first clinical trial","sourceName":"Rice University News"}],"keyFacts":[{"label":"FDA","value":"IDE approved April 2026"},{"label":"Indication","value":"Treatment-resistant depression"},{"label":"Program","value":"ARPA-H behavioral health"},{"label":"Origin","value":"Rice University research"}],"aliases":[],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":null,"stockExchange":null,"secCik":null,"revenueUsd":null,"revenueBasis":null,"revenueAsOf":null,"employeeCount":null,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-08-08T22:32:35.528Z","updatedAt":"2026-08-21T22:31:16.597Z"},"owner":null,"derived":{"trustTier":"unverified","currentPosture":null},"jsonLd":{"@context":"https://schema.org","@type":"Event","@id":"https://registry.deploy.report/deployments/motif-bci-germany-europe","url":"https://registry.deploy.report/deployments/motif-bci-germany-europe","name":"Motif BCI at Germany, Europe","identifier":"49a0443e-3414-40a3-9f90-cadc315966ae","startDate":"2024-06-01T00:00:00.000Z","location":{"@type":"Place","@id":"https://registry.deploy.report/locations/germany-europe","name":"Germany, Europe"},"organizer":{"@type":"Organization","@id":"https://registry.deploy.report/companies/motif-neurotech","name":"Motif Neurotech"},"about":{"@type":"Product","@id":"https://registry.deploy.report/models/motif-bci","name":"Motif BCI"},"publisher":{"@id":"https://deploy.report/#organization"}},"framework_metadata":{"framework_schema_version":"0.1.0","verification_status":"unreviewed","maturity_stage":"pilot","lifecycle_state":"active","architectural_position":{"cohort":"biometric","sub_cohorts":[]},"within_cohort_verified_vs_claimed_pair":null,"cap_flags":[],"verification_depth":{"sources_count":0,"primary_source_types":[]}}}